您的位置:首页 > 产品中心 > 4342-03-4, 达卡巴嗪
达卡巴嗪
Dacarbazine
产品价格查看更多规格...
产品编号 | 包装单位 | 单价(元) | 国内现货 | 国外库存 | 询价单 |
3074460 | 1400 |
产品别名
4342-03-4
达卡巴嗪
Dacarbazine
DTIC
5-(3,3-Dimethyl-1-triazenyl)imidazole-4-carboxamide
结构式
基本信息
Empirical Formula【经验(实验)分子式】 | C6H10N6O |
Molecular weight | 182.18 |
MDL number | MFCD00057167 |
PubChem Substance ID【PubChem化学物质编号】 | 329831122 |
NACRES | NA.24 |
General description【一般描述】 | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. |
Caution【注意】 | Please find SDS provided by EDQM here.. |
Other Notes【其他说明】 | Sales restrictions may apply. |
产品性质
grade【等级】 | pharmaceutical primary standard |
manufacturer/tradename | EDQM |
application(s) | pharmaceutical (small molecule) |
format【格式】 | neat |
storage temp.【储存温度】 | 2-8℃ |
SMILES string | CN(C)\N=N\c1[nH]cnc1C(N)=O |
InChI | 1S/C6H10N6O/c1-12(2)11-10-6-4(5(7)13)8-3-9-6/h3H,1-2H3,(H2,7,13)(H,8,9)/b11-10+ |
InChI key | FDKXTQMXEQVLRF-ZHACJKMWSA-N |
packaging【包装】 | Unit quantity: 20 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. |
安全信息
Pictograms【象形图】 | GHS07,GHS08 |
Signal word【警示用语:】 | Danger |
Hazard Statements | H302 + H312 + H332 - H315 - H319 - H335 - H340 - H350 |
Precautionary Statements | P201 - P280 - P301 + P312 + P330 - P302 + P352 + P312 - P304 + P340 + P312 - P308 + P313 |
Hazard Classifications【危险分类】 | Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Carc. 1B - Eye Irrit. 2 - Muta. 1B - Skin Irrit. 2 - STOT SE 3 |
Target Organs【靶器官】 | Respiratory system |
Storage Class Code【储存分类代码】 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects |
WGK | WGK 3 |